343 related articles for article (PubMed ID: 31480237)
1. Cancer Takes a Toll on Skeletal Muscle by Releasing Heat Shock Proteins-An Emerging Mechanism of Cancer-Induced Cachexia.
Sin TK; Zhang G; Zhang Z; Gao S; Li M; Li YP
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480237
[TBL] [Abstract][Full Text] [Related]
2. Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90.
Zhang G; Liu Z; Ding H; Zhou Y; Doan HA; Sin KWT; Zhu ZJ; Flores R; Wen Y; Gong X; Liu Q; Li YP
Nat Commun; 2017 Sep; 8(1):589. PubMed ID: 28928431
[TBL] [Abstract][Full Text] [Related]
3. Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90.
Wu HY; Trevino JG; Fang BL; Riner AN; Vudatha V; Zhang GH; Li YP
Cells; 2022 Sep; 11(17):. PubMed ID: 36078164
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways.
Zhang G; Liu Z; Ding H; Miao H; Garcia JM; Li YP
Sci Rep; 2017 May; 7(1):2273. PubMed ID: 28536426
[TBL] [Abstract][Full Text] [Related]
5. Molecular therapeutic strategies targeting pancreatic cancer induced cachexia.
Yakovenko A; Cameron M; Trevino JG
World J Gastrointest Surg; 2018 Dec; 10(9):95-106. PubMed ID: 30622678
[TBL] [Abstract][Full Text] [Related]
6. Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole.
Liu Z; Xiong J; Gao S; Zhu MX; Sun K; Li M; Zhang G; Li YP
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):636-647. PubMed ID: 34729960
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and Skeletal Muscle Wasting During Cachexia.
Webster JM; Kempen LJAP; Hardy RS; Langen RCJ
Front Physiol; 2020; 11():597675. PubMed ID: 33329046
[TBL] [Abstract][Full Text] [Related]
8. The Toll-Like Receptor/MyD88/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting during Cancer Cachexia.
Bohnert KR; Goli P; Roy A; Sharma AK; Xiong G; Gallot YS; Kumar A
Mol Cell Biol; 2019 Aug; 39(15):. PubMed ID: 31138662
[TBL] [Abstract][Full Text] [Related]
9. Mediators of cachexia in cancer patients.
Argilés JM; López-Soriano FJ; Busquets S
Nutrition; 2019 Oct; 66():11-15. PubMed ID: 31177056
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of peripheral muscle wasting in cardiac cachexia.
Filippatos GS; Anker SD; Kremastinos DT
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):249-54. PubMed ID: 15809526
[TBL] [Abstract][Full Text] [Related]
11. F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.
Sukari A; Muqbil I; Mohammad RM; Philip PA; Azmi AS
Semin Cancer Biol; 2016 Feb; 36():95-104. PubMed ID: 26804424
[TBL] [Abstract][Full Text] [Related]
12. Cancer cachexia is defined by an ongoing loss of skeletal muscle mass.
Baracos VE; Mazurak VC; Bhullar AS
Ann Palliat Med; 2019 Jan; 8(1):3-12. PubMed ID: 30685982
[TBL] [Abstract][Full Text] [Related]
13. The Role of Systemic Inflammation in Cancer-Associated Muscle Wasting and Rationale for Exercise as a Therapeutic Intervention.
Cole CL; Kleckner IR; Jatoi A; Schwarz EM; Dunne RF
JCSM Clin Rep; 2018; 3(2):. PubMed ID: 31134216
[TBL] [Abstract][Full Text] [Related]
14. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
15. The 2015 ESPEN Sir David Cuthbertson lecture: Inflammation as the driving force of muscle wasting in cancer.
Argilés JM
Clin Nutr; 2017 Jun; 36(3):798-803. PubMed ID: 27268093
[TBL] [Abstract][Full Text] [Related]
16. Cachexia in rheumatoid arthritis.
Walsmith J; Roubenoff R
Int J Cardiol; 2002 Sep; 85(1):89-99. PubMed ID: 12163213
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.
Bowen TS; Schuler G; Adams V
J Cachexia Sarcopenia Muscle; 2015 Sep; 6(3):197-207. PubMed ID: 26401465
[TBL] [Abstract][Full Text] [Related]
18. Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
Guo D; Wang C; Wang Q; Qiao Z; Tang H
Oncotarget; 2017 Jun; 8(24):39640-39648. PubMed ID: 28489606
[TBL] [Abstract][Full Text] [Related]
19. Muscle wasting in cancer.
Johns N; Stephens NA; Fearon KC
Int J Biochem Cell Biol; 2013 Oct; 45(10):2215-29. PubMed ID: 23770121
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia.
Melstrom LG; Melstrom KA; Ding XZ; Adrian TE
Histol Histopathol; 2007 Jul; 22(7):805-14. PubMed ID: 17455154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
